Vistagen Therapeutics, Inc. - Common Stock (VTGN)

Vistagen Therapeutics Inc is a biotechnology company focused on developing innovative therapies to address unmet needs in the treatment of neuropsychiatric disorders

The company specializes in creating novel drug candidates that aim to improve the lives of patients suffering from conditions such as anxiety, depression, and other mood disorders. Through its unique platform, Vistagen is advancing treatments that target specific pathways in the brain, with the goal of offering safer and more effective alternatives to conventional therapies currently available in the market.